CPRX

CPRX R&D Expenses

$11.48MTTM · USD

Period ending:

CPRX FY R&D ExpensesUSD
CPRX FY R&D Expenses2002-12-31: $137.68K2003-12-31: $0.002004-12-31: $378.25K2005-12-31: $1.46M2006-12-31: $989.14K2007-12-31: $2.99M2008-12-31: $8.71M2009-12-31: $5.10M2010-12-31: $2.31M2011-12-31: $3.38M2012-12-31: $2.66M2013-12-31: $8.10M2014-12-31: $10.12M2015-12-31: $11.80M2016-12-31: $11.37M2017-12-31: $11.38M2018-12-31: $19.92M2019-12-31: $18.84M2020-12-31: $16.50M2021-12-31: $16.94M2022-12-31: $19.79M2023-12-31: $93.15M2024-12-31: $12.65M2025-12-31: $12.71M$93.15M$0.00
2002-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CPRX r&d expenses history

Research and development spending. The available annual fiscal periods series contains 24 observations from Dec 31, 2002 to Dec 31, 2025.

Catalyst Pharmaceuticals Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
12,709,000
12,648,000
93,150,000
19,789,000
16,936,000
16,497,000
18,843,000
19,919,204
11,375,237
11,369,941
11,801,342
10,117,774
8,096,774
2,659,597
3,383,965
2,306,781
5,097,440
8,710,441
2,990,659
989,144
1,462,889
378,254
0
137,680

Compare r&d expenses

All CPRX financial metrics · CPRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.